News of Note—Dodgy stem cell clinics; New CMO for Context; UroGen payday – FierceBiotech
FierceBiotech |
News of Note—Dodgy stem cell clinics; New CMO for Context; UroGen payday
FierceBiotech In an article published today in the journal Regenerative Medicine, it turns out that the federal clinical-trials database ClinicalTrials.gov has allowed 18 ostensible clinical trials of unregulated stem cell therapies, that patients must to pay to … |
